The cost of the diagnostic odyssey of patients with suspected rare diseases
The diagnostic odyssey of patients with suspected rare diseases is associated with extensive healthcare utilization and high cost. Against this background, new ways to shorten the diagnostic journey have a high potential to decrease the financial burden related to rare diseases.
Authors
- Ursula Marschall (ORCID: https://orcid.org/0009-0008-2607-8996)
- Rick Glaubitz (ORCID: https://orcid.org/0000-0003-3846-4225)
- Gabriele Müller (ORCID: https://orcid.org/0000-0002-1591-0539)
- Falko Tesch (ORCID: https://orcid.org/0000-0001-8933-643X)
- Martin Seifert
- Luise Heinrich (ORCID: https://orcid.org/0000-0002-6320-4209)
- Jochen Schmitt (ORCID: https://orcid.org/0000-0003-0264-0960)
- Katrin Christiane Reber
Institutions
- BARMER GEK (DE)
- University Hospital Carl Gustav Carus (DE)
- Technische Universität Dresden (DE)
Publication Details
- Journal
- Orphanet Journal of Rare Diseases
- Published
- 2025-05-10
- DOI
- https://doi.org/10.1186/s13023-025-03751-y
- Citations
- 9
- Primary Topic
- Genomics and Rare Diseases
- Type
- article
- Field-Weighted Citation Impact
- 16.36
Funders
- Technische Universität Dresden